Evidence map›Paper›PMID 32303640›Full record

ArticleThe Journal of biological chemistry2020

Structure-function analyses of the G729R 2-oxoadipate dehydrogenase genetic variant associated with a disorder of l-lysine metabolism.

Xu Zhang, Natalia S Nemeria, João Leandro, Sander Houten, Michael Lazarus, Gary Gerfen, Oliver Ozohanics, Attila Ambrus, Balint Nagy, Roman Brukh and 1 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.1field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. HeterozygousGenes · 2021
    Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Xu ZhangDepartment of Chemistry, Rutgers, The State University of New Jersey, Newark, New Jersey 07102.
Natalia S NemeriaDepartment of Chemistry, Rutgers, The State University of New Jersey, Newark, New Jersey 07102 nemerianatalia@gmail.com.
João LeandroDepartment of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York 10029.
Sander HoutenDepartment of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York 10029 sander.houten@mssm.edu.ORCID 0000-0002-6167-9147
Michael LazarusDepartment of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York 10029.ORCID 0000-0002-6738-2563
Gary GerfenDepartment of Physiology and Biophysics, Albert Einstein College of Medicine, Bronx, New York 10641-2304.
Oliver OzohanicsDepartment of Medical Biochemistry, MTA-SE Laboratory for Neurobiochemistry, Semmelweis University, Budapest H-1094, Hungary.
Attila AmbrusDepartment of Medical Biochemistry, MTA-SE Laboratory for Neurobiochemistry, Semmelweis University, Budapest H-1094, Hungary.ORCID 0000-0001-6014-3175
Balint NagyDepartment of Medical Biochemistry, MTA-SE Laboratory for Neurobiochemistry, Semmelweis University, Budapest H-1094, Hungary.ORCID 0000-0003-3669-7041
Roman BrukhDepartment of Chemistry, Rutgers, The State University of New Jersey, Newark, New Jersey 07102.
Frank JordanDepartment of Chemistry, Rutgers, The State University of New Jersey, Newark, New Jersey 07102 frjordan@rutgers.edu.ORCID 0000-0003-1354-718X
Rutgers, The State University of New Jersey · USIcahn School of Medicine at Mount Sinai · USSemmelweis University · HUAlbert Einstein College of Medicine · US

Funding

Chemical and structural tools to study energy homeostasis pathways in cancer and diabetesR35GM124838 · NIGMS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Michael Block Lazarus · 2017 to 2026
$5.2M
Novel Treatment Options for Glutaric AciduriaR21HD088775 · NICHD · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI DEVITA, ROBERT J, HOUTEN, SANDER MICHEL · 2017 to 2018
$466k
Mechanistic Issues Related to Aging on Human 2-Oxoglutarate Dehydrogenase ComplexR15GM116077 · NIGMS · RUTGERS THE STATE UNIV OF NJ NEWARK · PI JORDAN, FRANK · 2015 to 2015
$369k
Genetic validation of DHTKD1 as a therapeutic target for the treatment of Glutaric Aciduria type 1R03HD092878 · NICHD · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI HOUTEN, SANDER MICHEL · 2017 to 2018
$170k
NICHD NIH HHS R03 HD092878NICHD NIH HHS R21 HD088775NIGMS NIH HHS R15 GM116077NIGMS NIH HHS R35 GM124838
6 · The paper itself

Abstract

2-Oxoadipate dehydrogenase (E1a, also known as DHTKD1, dehydrogenase E1, and transketolase domain-containing protein 1) is a thiamin diphosphate-dependent enzyme and part of the 2-oxoadipate dehydrogenase complex (OADHc) in l-lysine catabolism. Genetic findings have linked mutations in the

Indexed as

Genetic VariationFibroblastsHumansKetoglutarate Dehydrogenase ComplexKetone OxidoreductasesKineticsLysineModels, MolecularMolecular StructureStructure-Activity RelationshipDHTKD1 protein, humanKetoglutarate Dehydrogenase ComplexKetone OxidoreductasesLysine2-oxoadipate dehydrogenase2-oxoadipate dehydrogenase complexcell metabolismDNA damageH/D exchange mass spectrometrymass spectrometry (MS)multiple 2-oxoadipate dehydrogenase conformationsneurodegenerative diseaseprotein conformationsubstrate channeling

Identifiers

PMID32303640
PMCPMC7278340
OpenAlexW3016416997

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.